CellBion is a biotechnology and pharmaceutical startup founded in 2010 with the slogan "Advancing Global Healthcare with Innovative Radiopharmaceuticals". The company is based in South Korea and has recently received a significant KRW8.00B Venture Round investment on 26 October 2023 from prominent investors including Hana Ventures, Huons, and SINSIN-PHARM. CellBion is dedicated to revolutionizing healthcare through precision medicine, leveraging advanced technology and a highly experienced team to develop safe and effective solutions for medical imaging and therapeutic use. With a strong commitment to improving patient outcomes, the company aims to make a positive impact on global healthcare.
No recent news or press coverage available for CellBion.